The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter 
Professionals >> Visit The Body PROThe Body en Espanol
Ask the Experts About

AIDS-Related CancersAIDS-Related Cancers
Rollover images to visit our other forums!
  • Email Email
  • Glossary Glossary

Where do you see AIDS going in the future?
Feb 8, 2003

I have read that 2003 will be the busiest year ever for new drug launches, with at least five new products (T-20, FTC, Atazanavir and two reformulations) reaching the market in North America. With these new developements, and with future developments 5,10, or 20 yrs ahead, where do you see this disease going(no longer a death sentence, chronic like diabetes?) Will those who were infected in 2002 be around to benefit from the drugs of 2032? Your expert opinion would be greatly appreciated.

Response from Dr. Dezube

I do indeed believe that as more and more drugs come onto the market, AIDS will become more and more a chronic disease which needs to be treated with chronic therapy. Of course, this applies only to those who have access to drug therapy. In addition to drug access, many other barriers exist. Adherance to drug therapy is a major issue. This is really not the forum for such a discussion. I would encourage you to surf many of the fine answers to this subject on website.

lump on my testicle
primary effusion lymphoma

  • Email Email
  • Glossary Glossary



This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint